Endometriosis and inflammatory immune responses: Indian experience
American Journal of Reproductive Immunology · 2023-02 · 89 (2)
DOI: 10.1111/aji.13590 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Reproductive Immunology, 2022-07. Verfasst von Rahul K Gajbhiye. Beteiligte Einrichtung: Clinical Research Laboratory, ICMR-National Institute for Research in Reproductive and Child Health, Mumbai, Maharashtra, India. Hauptthemen laut MEDLINE: Endometriosis. Die Arbeit wurde bisher 34-mal zitiert (Crossref) und nennt 124 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Wellcome Trust, DBT-Wellcome Trust India Alliance.
Abstract (Originalsprache)
Endometriosis is a public health disorder affecting ∼ 247 million women globally and ∼ 42 million women in India. Women with endometriosis suffer from dysmenorrhea, chronic pelvic pain, dyspareunia, dyschezia, fatigue, depression, and infertility leading to significant socioeconomic impact and morbidity. The etiology of endometriosis is not understood well even after 100 years of research. Currently, there is no permanent cure for endometriosis. The inflammatory immune response is one of the important features of etiopathogenesis of endometriosis and therefore understanding the inflammatory immune response would lead to a better understanding of this enigmatic disorder and may also lead to biomarker discovery for diagnosis of endometriosis. We investigated the autoimmune etiology of endometriosis in the Indian population. Using the proteomics approach, anti‐endometrial antibodies (AEAs) were detected in Indian women with endometriosis [anti‐endometrial antibodies ‐ tropomyosin 3 (TPM3), stomatin‐like protein2 (SLP‐2), and tropomodulin 3 (TMOD3)]. The studies on AEAs provided a better understanding of autoimmune mechanisms in endometriosis. All three subtypes of endometriosis; superficial peritoneal, ovarian endometrioma, and deep infiltrating endometriosis were reported in Indian women. In this review, we discuss our experiences of the inflammatory immune response, autoimmunity, comorbidities, and clinical phenotypes in women with endometriosis in India.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Clinical Research Laboratory, ICMR-National Institute for Research in Reproductive and Child Health, Mumbai, Maharashtra, India.
ORCID-Profile: Rahul K Gajbhiye
Förderung
- Wellcome Trust
- DBT-Wellcome Trust India Alliance
Zitieren
APA
Gajbhiye, R. K. (2023). Endometriosis and inflammatory immune responses: Indian experience. American Journal of Reproductive Immunology, 89(2). https://doi.org/10.1111/aji.13590
Vancouver
Gajbhiye RK. Endometriosis and inflammatory immune responses: Indian experience. American Journal of Reproductive Immunology. 2023;89(2). doi:10.1111/aji.13590
BibTeX
@article{Gajbhiye2023,
author = {Gajbhiye, Rahul K},
title = {Endometriosis and inflammatory immune responses: Indian experience},
journal = {American Journal of Reproductive Immunology},
year = {2023},
volume = {89},
number = {2},
doi = {10.1111/aji.13590}
}
EUVIMED